Wednesday, March 30, 2016

FDA relaxes chemical abortion rules to match desires of abortion providers

On March 30, 2016, the Food and Drug Administration altered its guidelines for using the drug Mifeprex (also known as mifepristone or RU-486) for an abortion. 

Previous guidelines called for the drug to be used in the first 49 days of pregnancy, that women should take three trips to the abortion provider and 3 tablets of 200 mgs of Mifeprex be used.  The new guidelines extend the time the drug can be used to 70 days, reduce the number of visits to the abortion provider to two and the number of 200 mg tablets of Mifreprex to one.  

The FDA’s previous web page on Mifeprex also mentioned how several women had died from sepsis caused by the bacteria Clostridium sordellii after undergoing chemical abortions.  The updated web page no longer has this information on it. 

The new guidelines also allow for non-physicians (such as physician assistants, nurse practitioners and midwives) to provide chemical abortions as being a physician is not one of their guidelines. 

For years, abortion providers have been doing chemical abortions and ignoring the FDA guidelines.  In response to these abortionists, some states passed legislation requiring abortionists to follow the FDA guidelines and now the FDA has altered their guidelines to match how abortionists have been using Mifeprex. 

According to the FDA's 2011 adverse events report, at least 14 women have died after taking the chemical abortion drugs.